logo
Mum who nearly died after falling sick in Spain issues warning after anti-sickness pills left her ‘acting possessed'

Mum who nearly died after falling sick in Spain issues warning after anti-sickness pills left her ‘acting possessed'

The Sun3 days ago

A MUM is urging Brits to be careful buying medicine on holiday - after she nearly died when an over-the-counter anti-sickness tablet left her acting "possessed".
Keira Morrison had been unwell during her family holiday to Salou, Spain, and had been throwing up around 10 times a day.
4
4
When Dioralyte didn't improve the 29-year-old's symptoms, her partner Liam Bridgeman, 33, went to a nearby pharmacy and bought her some anti-sickness tablets for 1.90 euro.
Metoclopramide is an anti-sickness medication that is only available on prescription in the UK, however it's available over the counter in Spain.
After two days of taking the tablets, the former hairdresser's jaw suddenly "locked" as they sat in their hotel room - and she soon lost control of her body.
A panicked Keira and Liam went to their hotel manager for help and once they showed him the tablets he offered to drive the couple to a nearby medical centre.
Here the mum-of-two deteriorated quickly and began to act "possessed" - losing control of her arms and legs and her eyes rolling back in her head.
She admits it was so bad she "thought it was the end".
Staff put her on an IV drip while they ordered an ambulance to take her to hospital in Tarragona, where doctors manged to ease her symptoms with an injection.
It has since emerged that the recommended dosage is one 10mg tablet three times a day - but Keira claims the pharmacist had told her to take two of the tablets at once.
This meant she was taking twice the recommended dosage on each occasion.
She is now raising awareness about the terrifying experience online and about the potential risks of adverse reactions to common medications, particularly if more easily available with prescriptions when on holiday.
Beware 3 of the most dangerous medicines in the world - including one found in almost EVERY home
Keira, from Liverpool, Merseyside, said: "Liam said it was like I was possessed.
"I thought it was the end, I did. It was not a nice experience at all.
"It was like I wasn't in my body, it was like someone had control over my body. That's how I felt and I did feel like I was going to die.
"There were leaflets on the wall and when I was looking at the words, I couldn't see the words. They were going blurry.
"I was pleading with them [the doctors] like, 'please help me.'
"At the point before I had the injection my head was banging off the bed, my eyes were going to the back of my head and flickering. My legs and arms were flying everywhere.
It felt like I was having a seizure. I just wanted the feeling to stop
Keira Morrison
"It felt like I was having a seizure. I just wanted the feeling to stop, I've never experienced a feeling like that in my life. I was screaming, 'please help me, please help me!'
"If I didn't go to hospital when I did I probably would have thrown myself off the balcony because I wanted the feeling to stop that much. I was crying, screaming."
Keira said one of the doctors in the hospital explained that she had a reaction to the tablets.
After spending a night in hospital Keira left the following day because she was due to fly home and she said she thinks she experienced a side effect called tardive dyskinesia.
According to Mind, this is a condition where your face, body or both make sudden, irregular and uncontrollable movements.
This is a known potential side effect of the medication and a 2014 report by the European Medicines Agency's Committee on Medicinal Products for Human Use and recommended restricting the dose to "help minimise the risk of potentially serious neurological adverse effects".
4
Since returning to the UK, she has been to her doctor to have an allergy test and to have her heart checked as she had been experiencing palpitations.
Keira said: "My doctor did say in the UK you've got to have a prescription to get that medication.
"You can't get that over the counter here. You shouldn't be selling that over the counter.
"It has scared us. We have another holiday booked and we are in talks of cancelling. We're in shock and we can't believe it happened.
"I'll never ever buy anything over the counter again.
"If I ever do go away now I'll make sure I've got my own anti-sickness medication from the UK and it was something I'd had before.
"I can't describe the feeling, it was horrendous. I wouldn't wish it on my own enemy."
Accord, the manufacturer of the tablets, have been contacted for comment.
Safety measures when buying medicines abroad
IF medication needs to be acquired abroad, it's recommended to purchase from licensed pharmacies in large cities and to verify that the medication contains the same active ingredient as the one typically taken.
Also:
Whenever possible, obtain all required medications before travelling, as this avoids the risk of purchasing falsified medicines.
Do not purchase medicines from street markets or unregulated online sources, as these are high-risk areas for counterfeit products.
Discuss the need for medications abroad with your doctor or pharmacist, who can provide guidance on obtaining them safely and legally.
Be cautious of misspellings or incorrect packaging, as these can be indicators of falsified medications.
Some embassies can provide lists of reliable pharmacies in the country you are visiting.
Be cautious when buying medicines online, as there is a high risk of purchasing counterfeit products.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UK Pharmaceutical industry at risk from government's 'sky-high' rebates system
UK Pharmaceutical industry at risk from government's 'sky-high' rebates system

Daily Mail​

timean hour ago

  • Daily Mail​

UK Pharmaceutical industry at risk from government's 'sky-high' rebates system

The UK's status as a leader in medical research is at risk from 'sky-high and unpredictable' repayments pharmaceutical firms hand the Government, says an industry boss. Richard Torbett, chief executive of the Association of the British Pharmaceutical Industry, said the rebate system – where firms repay money they make through selling medicines to the NHS – was sending 'a terrible message to international investors'. Rachel Reeves promised to support 'the UK's strengths in life sciences' and 'ensure patients get rapid access to the most clinically and cost-effective new technologies'. The Treasury plans to invest up to £520million in drug manufacturing in the next five years. Another £600million is earmarked for a health data research service to accelerate the discovery of new medicines. But Torbett said more was needed. 'Over the past decade, accounting for inflation, the NHS budget has grown by a third in real terms, while investment in the most rigorously cost-benefit-tested part of health spending – investment in the medicines needed to treat people – has fallen from around 11 per cent to 9 per cent of the health budget,' he added. And he attacked plans to increase what drug companies must repay from drug sales to 31.3 per cent, from 15.5 per cent. 'The sky-high and unpredictable payment rates send a terrible message to international investors when the UK is trying to position life sciences research and development as an engine for health and growth. For the sake of patients, the NHS and the economy, we need a commitment to bring these unsustainable rates down.'

The Inkey List's glycolic acid exfoliating stick worked magic on my keratosis pilaris
The Inkey List's glycolic acid exfoliating stick worked magic on my keratosis pilaris

The Independent

timean hour ago

  • The Independent

The Inkey List's glycolic acid exfoliating stick worked magic on my keratosis pilaris

If you struggle with keratosis pilaris (also known as strawberry skin – a build-up of keratin within our skin pores) or sore razor bumps, then listen up. The much loved-affordable skincare brand The Inkey List may have produced the answer to our collective grumbles. Having sold out after its original launch, this stick claims to reduce the appearance of keratosis pilaris, razor bumps, hyper-pigmentation, breakouts and ingrown hairs. Results are promised after just one week, and drastic improvements are said to be visible after a month of consistent use. How does this miracle product work? Well, it's a combination of skin-loving hero ingredients. The glycolic acid is used to exfoliate the skin's surface and remove dead cells that leave the skin feeling rough, bumpy and uneven in tone. Salicylic acid helps to unclog oily pores, which is what causes issues like breakouts and ingrown hairs. Finally, shea butter offers a hydrating and moisturising effect. Chemical exfoliants have become the way of the future, and after testing this product, I'm beginning to see why. Here's how I got on with this miracle stick. How I tested Using the exfoliating stick every night for the last two months, I targeted keratosis pilaris on my arm, as well as underarm razor bumps and dry heels and elbows. I followed instructions carefully, starting by only using the stick two or three times a week and building up to every night once my skin had gotten used to it. To assess the product's efficacy, I looked for two things, appearance and texture. I noted any decrease in redness and improvement in brightness and paid close attention to any changes in the dryness or bumpiness of my skin.

Aging: Healthy habits could offset stroke, dementia, depression risk
Aging: Healthy habits could offset stroke, dementia, depression risk

Medical News Today

timean hour ago

  • Medical News Today

Aging: Healthy habits could offset stroke, dementia, depression risk

New research finds certain diseases may be more common in people with a biomarker of aging but not in those with healthy lifestyles. Ivan Gener/Stocksy Age can increase a person's risk for several health conditions, including stroke, dementia, and late-life depression. A new study has identified an aging biomarker that is more common in people who develop stroke, dementia, and depression as they age. Researchers found that study participants who followed a healthy lifestyle appeared to offset the risks associated with this aging biomarker. 'Stroke and dementia are among the most prevalent age-related diseases, affecting millions worldwide and representing major health challenges for individuals, families, and healthcare systems,' Tamara N. Kimball, MD, a post-doctoral research fellow in the Brain Care Labs at Mass General Brigham told Medical News Today . 'With their impact expected to grow dramatically as populations age — and the number of people ages 60 and over projected to increase from 1 billion in 2020 to 1.4 billion by 2030 — developing effective prevention strategies has become urgent,' she said. Kimball is the lead author of a new study recently published in Neurology, the medical journal of the American Academy of Neurology, that has identified an aging biomarker that is more common in people who develop stroke, dementia, and depression as they age. However, researchers found that following a healthy lifestyle offsets the risk of the diseases associated with this aging biomarker. For this study, researchers analyzed medical records for more than 356,000 adults with a median age of 56 living in the U.K. 'Imagine your shoelaces have plastic tips that protect them from fraying — telomeres work similarly for your DNA,' Kimball explained. 'Every time your cells divide, which happens constantly as your body repairs and maintains itself, these protective tips get a little shorter. As they become shorter over time, their ability to protect DNA diminishes, leading to cellular aging and an increased susceptibility risk of age-related diseases.' 'The length of telomeres in white blood cells (leukocytes) can serve as a marker of biological aging and is influenced by genetic factors, lifestyle choices, and environmental stressors,' she added. At the study's conclusion, researchers found that study participants with the shortest telomere length had 5.82 cases per 1,000 person-years (number of people in the study and amount of time each person spent in the study) of the brain diseases dementia, stroke, and late-life depression, compared to 3.92 cases for participants with the longest telomeres. 'This shows people with the shortest telomeres presented (with) these brain diseases about 1.5 times more than those with the longest telomeres, demonstrating how biological aging affects brain health,' Kimball said. Scientists also discovered that study participants with short telomeres who had brain disease risk factors such as high blood pressure and smoking were 11% more likely to develop stroke, dementia, or depression than those with long telomeres. 'Our results demonstrate that individuals with low Brain Care Score — reflecting less favorable lifestyle factors like high blood pressure and smoking — consistently showed elevated risk for stroke, dementia, and depression when they also had shorter telomeres,' Kimball said. ' This suggests a compounded risk effect where biological aging and poor lifestyle choices increase disease susceptibility,' she said. Interestingly, Kimball and her team also found that participants with short telomeres, but who had high Brain Care Scores, did not have a higher risk of developing the studied brain diseases. 'In individuals with high Brain Care Score, the impact of leukocyte telomere length on disease risk was not significant,' Kimball explained. 'This may suggest that adopting healthier lifestyles and improving modifiable risk factors can mitigate the negative effects of having shorter telomeres.' 'Research shows that approximately 45% of dementia cases and up to 85% of strokes are linked to factors we can modify — like blood pressure, diet, and exercise,' she continued. 'Understanding the biological mechanisms by which lifestyle interventions influence cellular aging processes is essential for validating prevention strategies and developing more targeted, evidence-based interventions for brain health.' 'Our findings suggest that adopting healthier lifestyles and improving modifiable risk factors might mitigate some of the negative effects of shorter telomeres, which reflect adverse lifestyle choices in addition to social and environmental determinants of health earlier in life. In short, it is never too late to start taking better care of your brain.' — Tamara N. Kimball, MD MNT had the opportunity to speak with Clifford Segil, DO, an adult neurologist in private practice in Santa Monica, CA, who is also on staff at Providence St. John's Health Center in Santa Monica, CA, about this study. 'I am excited to see this research indicating a common cause of these three pathologies to develop into a possible treatment for telomere length protection or extension which could possibly decrease the occurrence of stroke, dementia, and depression in my elderly patients.' — Clifford Segil, DO Segil said that any time a common pathology is found between disparate neurological disease states, it is exciting as this research may stimulate a novel therapy. 'I often share with my patients that an ounce of prevention is worth a pound of treatment and studies like this support my desire to help my patients with common sense practical brain health preventative strategies,' he stated. For the next steps in this research, Segil said he would like to see this research group focus on specific lifestyle traits which cause patients to be able to maintain their 'large' telomere length and therefore decrease risk of stroke, dementia, and depression to figure out what to advise my patients to do for good brain health. 'I would then want them to do the reverse and figure out which habits or lifestyle choices specifically result in 'short' telomere lengths so I could advise my patients what to avoid in life,' he added. MNT also spoke with Jasdeep S. Hundal, PsyD, ABPP-CN, director of The Center for Memory & Healthy Aging at Hackensack Meridian Jersey Shore University Medical Center, and associate professor of psychiatry and neurology at Hackensack Meridian Health School of Medicine in New Jersey, about this research who commented that findings are not entirely surprising, but do add value. 'Short leukocyte telomere length has long been viewed as a general marker of biological aging and this study seems to support this association, especially for people with unhealthy lifestyles.' — Jasdeep S. Hundal, PsyD, ABPP-CN 'This reinforces what we see clinically in that modifiable risk factors remain central, even in the context of genetic or biological vulnerability, to brain health as we age even if the findings are correlational. It is interesting to speculate that short telomeres aren't necessarily causing these brain diseases, but they are a warning sign, especially in the setting of poor lifestyle choices,' Hundal explained. 'The burden of age-related brain diseases is rapidly rising, and we still have no cure for the most serious dementias like Alzheimer's disease,' he continued. 'Most of the risk factors for these diseases are modifiable, so there is real potential for prevention or risk reduction, even in people who may already be showing signs of biological aging.' Hundal said that studies like this highlight that maintaining a healthy lifestyle is not just 'good advice,' but can have genuine brain health consequences if someone is biologically vulnerable. 'We need more research identifying which interventions actually make a difference, for whom, and how to implement them in real-world settings,' he added. 'The focus should always be on translating findings like these into concrete strategies that help patients maintain brain health and independence for as long as possible.' Cholesterol Hypertension Stroke Alzheimer's / Dementia Seniors / Aging

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store